» Articles » PMID: 19935648

A Novel Intracellular Protein Delivery Platform Based on Single-protein Nanocapsules

Overview
Journal Nat Nanotechnol
Specialty Biotechnology
Date 2009 Nov 26
PMID 19935648
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

An average cell contains thousands of proteins that participate in normal cellular functions, and most diseases are somehow related to the malfunctioning of one or more of these proteins. Protein therapy, which delivers proteins into the cell to replace the dysfunctional protein, is considered the most direct and safe approach for treating disease. However, the effectiveness of this method has been limited by its low delivery efficiency and poor stability against proteases in the cell, which digest the protein. Here, we show a novel delivery platform based on nanocapsules consisting of a protein core and a thin permeable polymeric shell that can be engineered to either degrade or remain stable at different pHs. Non-degradable capsules show long-term stability, whereas the degradable ones break down their shells, enabling the core protein to be active once inside the cells. Multiple proteins can be delivered to cells with high efficiency while maintaining low toxicity, suggesting potential applications in imaging, therapy and cosmetics fields.

Citing Articles

Excision of HIV-1 Provirus in Human Primary Cells with Nanocapsuled TALEN Proteins.

Zhao M, Wen J, Chen I, Liu J, Lu Y ACS Appl Bio Mater. 2025; 8(2):1227-1239.

PMID: 39889258 PMC: 11892523. DOI: 10.1021/acsabm.4c01544.


Barcoded screening identifies nanocarriers for protein delivery to kidney.

Wang L, Zhou W, Chen H, Jia X, Zheng P, Jiang H Nat Commun. 2025; 16(1):899.

PMID: 39837887 PMC: 11751284. DOI: 10.1038/s41467-025-56257-3.


Genetic transformation in conifers: current status and future prospects.

Zhao H, Zhang J, Zhao J, Niu S For Res (Fayettev). 2024; 4:e010.

PMID: 39524432 PMC: 11524282. DOI: 10.48130/forres-0024-0007.


A small-molecule carrier for the intracellular delivery of a membrane-impermeable protein with retained bioactivity.

Ma X, Zhang Z, Barba-Bon A, Han D, Qi Z, Ge B Proc Natl Acad Sci U S A. 2024; 121(44):e2407515121.

PMID: 39436658 PMC: 11536097. DOI: 10.1073/pnas.2407515121.


Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications.

Cao Z, Liu C, Wen J, Lu Y Adv Mater. 2024; 36(41):e2403116.

PMID: 38819929 PMC: 11571700. DOI: 10.1002/adma.202403116.


References
1.
Ames B, Shigenaga M, Hagen T . Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993; 90(17):7915-22. PMC: 47258. DOI: 10.1073/pnas.90.17.7915. View

2.
Finkel T, Holbrook N . Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408(6809):239-47. DOI: 10.1038/35041687. View

3.
Vyas S, Singh A, Sihorkar V . Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst. 2001; 18(1):1-76. View

4.
Folkes L, Wardman P . Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol. 2001; 61(2):129-36. DOI: 10.1016/s0006-2952(00)00498-6. View

5.
Caron N, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K . Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther. 2001; 3(3):310-8. DOI: 10.1006/mthe.2001.0279. View